Fundraising Fox
Quotient Therapeutics
76 employees on LinkedIn · 1 known investors
Find your way into Quotient Therapeutics
Sign up to see every warm intro you have to Quotient Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Quotient Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform. It was founded by Flagship Pioneering in collaboration with academic co-founders.
Investors · 1
Flagship Pioneering✓ confirmed by Quotient TherapeuticsCambridge · $500K – $10M
How we know: Flagship Pioneering's portfolio page · the company's own site · a partner's Signal profile · funding news · startupmag.co.uk · Not right? Tell us
Funding
SEC filings, press & company announcements$50M disclosed across 1 of 2 rounds · 2023–2025
- $50MraisedNov 2023 · 2 sources
Flagship Pioneering (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Quotient Therapeutics do?
- Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform. It was founded by Flagship Pioneering in collaboration with academic co-founders.
- Who are Quotient Therapeutics's investors?
- Quotient Therapeutics's investors include Flagship Pioneering.
- How much funding has Quotient Therapeutics raised?
- Quotient Therapeutics has disclosed $50M raised across 1 of its 2 known rounds.